Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
Sponsor
AstraZeneca (Industry)
Overall Status
Completed
CT.gov ID
NCT00573222
Collaborator
(none)
330
13
6
25.4
4.2
Study Details
Study Description
Brief Summary
This is a 3-month non-interventional, observational study on patients with moderate and severe asthma.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
Study Design
Study Type:
Observational
Actual Enrollment
:
330 participants
Time Perspective:
Prospective
Official Title:
Non-interventional Surveillance of Effectiveness of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the Treatment of Moderate and Severe Asthma
Study Start Date
:
Nov 1, 2007
Actual Primary Completion Date
:
May 1, 2008
Actual Study Completion Date
:
May 1, 2008
Outcome Measures
Primary Outcome Measures
- To evaluate & describe asthma control in adult patients w/moderate to severe asthma treated w/Symbicort SMART following the frequency, type & severity of symptoms through the Asthma Control Questionnaire. []
Secondary Outcome Measures
- to evaluate the safety of Symbicort SMART treatment through the number and type of reported adverse events 2. assessment of patient's satisfaction with the treatment 3.assessment of physician's satisfaction with the treatment []
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patients with moderate and severe asthma on Symbicort SMART treatment
Exclusion Criteria:
- Under 18 years old
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Research Site | Cakovec | Croatia | ||
| 2 | Research Site | Dubrovnik | Croatia | ||
| 3 | Research Site | Osijek | Croatia | ||
| 4 | Research Site | Pozega | Croatia | ||
| 5 | Research Site | Pula | Croatia | ||
| 6 | Research Site | Rijeka | Croatia | ||
| 7 | Research Site | Senj | Croatia | ||
| 8 | Research Site | Sibenik | Croatia | ||
| 9 | Research Site | Slavonskibrod | Croatia | ||
| 10 | Research Site | Vinkovci | Croatia | ||
| 11 | Research Site | Vukovar | Croatia | ||
| 12 | Croatia | Zadar | Croatia | ||
| 13 | Research Site | Zagreb | Croatia |
Sponsors and Collaborators
- AstraZeneca
Investigators
- Study Director: Anan Marija Gjurovic, AstraZeneca
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00573222
Other Study ID Numbers:
- NIS-RHR-SYM-2007/1
First Posted:
Dec 14, 2007
Last Update Posted:
Dec 1, 2010
Last Verified:
Nov 1, 2010
Keywords provided by ,
,
Additional relevant MeSH terms: